Evolus boosts balance sheet ahead of Q4 results, shares rise

Daewoong Pharma

23/03/2021 17:42

** Shares of medical aesthetics co  EOLS.O  jump 12.5% to
$16.18 in afternoon trade 
    ** Announces several deals with strategic partner Daewoong
Pharmaceutical Co Ltd to strengthen co's balance sheet
 urn:newsml:reuters.com:*:nGNXbd0y7H
    ** Daewoong to pay $25.5 mln in cash to Evolus and eliminate
$127.4 mln of Evolus debt and milestone payments
    ** "We appreciate the financial commitments from our
strategic partner Daewoong which allow us to invest directly
into accelerating the growth of our neurotoxin business" - CEO
    ** EOLS to report Q4 results on Wednesday
    ** Stock surged 378.5% YTD

 (Reporting by Sanjana Shivdas in Bengaluru)
 ((SanjanaSitara.Shivdas@thomsonreuters.com; within U.S. +1 646
223 8780, outside U.S. +91 80 6749 1642; Twitter:
@SanjanaShivdas;))